Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism
- Authors: Slominsky P.A.1, Shadrina M.I.1, Kolomin T.A.1, Stavrovskaya A.V.2, Filatova E.V.1, Andreeva L.A.1, Illarioshkin S.N.2, Myasoedov N.F.1
-
Affiliations:
- Institute of Molecular Genetics RAS
- Scientific Centre of Neurology
- Issue: Vol 474, No 1 (2017)
- Pages: 106-109
- Section: General Biology
- URL: https://ogarev-online.ru/0012-4966/article/view/154057
- DOI: https://doi.org/10.1134/S0012496617030048
- ID: 154057
Cite item
Abstract
Parkinson’s disease (PD) is the second most common severe neurodegenerative disorder that is characterized by progressive degeneration of dopaminergic neurons (DA neurons) in the substantia nigra pars compacta (SNpc) region of the brain. In the present study, we investigated the effects of the synthetic regulatory peptides Semax (analog of an ACTH 4-10 fragment (ACTH4-10)) and Selank (analog of immunomodulatory taftsin) on behavior of rats with 6-hydroxidopamine (6-OHDA) induced PD-like parkinsonism. It was showed that both peptides did not affect motor activity of rats in elevated cross shaped maze and passive defensive behavior of the animals. At the same time, Selank decreased level of anxiety of rats with toxic damage of DA neurons in elevated cross shaped maze. Previously such effects of Selank were revealed in healthy rodents (rats and mice) with different models of psycho-emotional stress. Therefore, toxic damage of substantia nigra does not affect the response of the rat organism on this peptide.
About the authors
P. A. Slominsky
Institute of Molecular Genetics RAS
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
M. I. Shadrina
Institute of Molecular Genetics RAS
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
T. A. Kolomin
Institute of Molecular Genetics RAS
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
A. V. Stavrovskaya
Scientific Centre of Neurology
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
E. V. Filatova
Institute of Molecular Genetics RAS
Author for correspondence.
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
L. A. Andreeva
Institute of Molecular Genetics RAS
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
S. N. Illarioshkin
Scientific Centre of Neurology
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
N. F. Myasoedov
Institute of Molecular Genetics RAS
Email: filatovaev@img.ras.ru
Russian Federation, Moscow
Supplementary files
